A detailed history of Sharp Financial Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sharp Financial Services, LLC holds 5,750 shares of BMY stock, worth $323,725. This represents 0.23% of its overall portfolio holdings.

Number of Shares
5,750
Previous 10,450 44.98%
Holding current value
$323,725
Previous $434 Million 31.45%
% of portfolio
0.23%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$39.66 - $51.75 $186,401 - $243,225
-4,700 Reduced 44.98%
5,750 $298 Million
Q2 2024

Jul 15, 2024

BUY
$40.25 - $52.99 $420,612 - $553,745
10,450 New
10,450 $434 Million
Q1 2024

Aug 13, 2024

BUY
$47.98 - $54.4 $175,127 - $198,560
3,650 Added 80.22%
8,200 $445 Million
Q4 2023

Aug 13, 2024

SELL
$48.48 - $57.85 $286,032 - $341,315
-5,900 Reduced 56.46%
4,550 $233 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sharp Financial Services, LLC Portfolio

Follow Sharp Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sharp Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sharp Financial Services, LLC with notifications on news.